Projects per year
Fingerprint
Dive into the research topics where Xiaoyang Xu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 4 Finished
-
Developing Functional Ferritin Nanocages for Blood Brain Barrier Traversing and Cellular Delivery
Xu, X. (PI)
5/1/20 → 4/30/25
Project: Research project
-
Improving Post-MI Cardiac Function via Delivery of Mydgf using an Injectable and Fluorescent Polyester-Based Hydrogel
Xu, X. (PI)
1/1/19 → 12/31/20
Project: Research project
-
I-Corps: Nanomedicine As Treatment For Drug-Resistant Bacteria
Xu, X. (PI)
3/1/17 → 11/30/18
Project: Research project
-
Sensitize Chemoresistant Breast Cancer by Nano-delivery of siRNA and Cisplatin
Xu, X. (PI)
4/1/12 → 1/1/15
Project: Research project
-
A combinatorial siRNA and mRNA approach for obesity treatment using targeting lipid nanoparticles
Stewart, W., Hu, B., Li, F., Huang, J., Liu, Z., Zhang, C., Tang, M., Zhang, X. Q. & Xu, X., Jul 10 2025, In: Journal of Controlled Release. 383, 113857.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Adiponectin mRNA Conjugated with Lipid Nanoparticles Specifically Targets the Pathogenesis of Type 2 Diabetes
El-Araby, R. E., Tu, Q., Xie, Y., Aboushousha, T., Li, Z., Xu, X., Zhu, Z. X., Dong, L. Q. & Chen, J., Apr 2025, In: Aging and Disease. 16, 2, p. 1059-1079 21 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Delivery of mRNA Encoding Interleukin-12 and a Stimulator of Interferon Genes Agonist Potentiates Antitumor Efficacy through Reversing T Cell Exhaustion
Wang, B., Tang, M., Chen, Q., Ho, W., Teng, Y., Xiong, X., Jia, Z., Li, X., Xu, X. & Zhang, X. Q., Jun 18 2024, In: ACS Nano. 18, 24, p. 15499-15516 18 p.Research output: Contribution to journal › Article › peer-review
26 Scopus citations -
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
Bai, X., Chen, Q., Li, F., Teng, Y., Tang, M., Huang, J., Xu, X. & Zhang, X. Q., Dec 2024, In: Nature communications. 15, 1, 6844.Research output: Contribution to journal › Article › peer-review
Open Access52 Scopus citations -
Prevent and Reverse Metabolic Dysfunction-Associated Steatohepatitis and Hepatic Fibrosis via mRNA-Mediated Liver-Specific Antibody Therapy
Zhang, C., Teng, Y., Bai, X., Tang, M., Stewart, W., Chen, J. J., Xu, X. & Zhang, X. Q., Dec 17 2024, In: ACS Nano. 18, 50, p. 34375-34390 16 p.Research output: Contribution to journal › Article › peer-review
10 Scopus citations
Press/Media
-
Research from New Jersey Institute of Technology Broadens Understanding of Pyroptosis (mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy)
7/28/23
1 item of Media coverage
Press/Media: Press / Media
-
Studies from New Jersey Institute of Technology Add New Findings in the Area of Gene Therapy (Enzyme-catalyzed One-step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-based Mrna Covid-19 Vaccines)
11/25/22
1 item of Media coverage
Press/Media: Press / Media
-
New Jersey Institute of Technology and Rutgers the State University of New Jersey File United States Patent Application for Injectable Formulations of Anesthetics for Any Pathological Pain
12/4/21
1 item of Media coverage
Press/Media: Press / Media
-
New Jersey Institute of Technology Seeks Patent for Nanoparticle Depot for Controlled and Sustained Gene Delivery
10/29/21
1 item of Media coverage
Press/Media: Press / Media
-
NJIT'S XU IS DEVELOPING A TIMED-RELEASE MRNA VACCINE WITH AN EXTENDED SHELF LIFE
8/31/21
1 item of Media coverage
Press/Media: Press / Media